Warit Ruanglertboon

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Hospital pharmacy

Journal of cancer research and clinical oncology

Pharmaceuticals (Basel, Switzerland)

International journal of clinical oncology

Prince of Songkla University (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Prince of Songkla University

Thailand

MSC :: Pharmacology

Prince of Songkla University

Thailand

BSC

Publications

Nuntapong Boonrit, Nansinee Klaidokchan, Apisit Niyomdecha, Janyaporn Noppamas, Krit Suknuntha, Pharsai Prasertsan, Supatcha Thaworncheep, Warit Ruanglertboon
Development and Evaluation of a Prototype Mobile Application for Intravenous Drug Dose Calculation in Overweight and Obese Thai Children: Precision Dosing in Practice. Hospital pharmacy 59 (4) (2024)
Nuntapong Boonrit, Nansinee Klaidokchan, Apisit Niyomdecha, Janyaporn Noppamas, Krit Suknuntha, Pharsai Prasertsan, Supatcha Thaworncheep, Warit Ruanglertboon
Development and Evaluation of a Prototype Mobile Application for Intravenous Drug Dose Calculation in Overweight and Obese Thai Children: Precision Dosing in Practice. Hospital pharmacy 59 (4) (2024)
Nuntapong Boonrit, Nansinee Klaidokchan, Apisit Niyomdecha, Janyaporn Noppamas, Krit Suknuntha, Pharsai Prasertsan, Supatcha Thaworncheep, Warit Ruanglertboon
Development and Evaluation of a Prototype Mobile Application for Intravenous Drug Dose Calculation in Overweight and Obese Thai Children: Precision Dosing in Practice. Hospital pharmacy 59 (4) (2024)
Nuntapong Boonrit, Nansinee Klaidokchan, Apisit Niyomdecha, Janyaporn Noppamas, Krit Suknuntha, Pharsai Prasertsan, Supatcha Thaworncheep, Warit Ruanglertboon
Development and Evaluation of a Prototype Mobile Application for Intravenous Drug Dose Calculation in Overweight and Obese Thai Children: Precision Dosing in Practice. Hospital pharmacy 59 (4) (2024)
Patcharaphun Kidpun, Warit Ruanglertboon, Rapeepun Chalongsuk
State-of-the-art knowledge on the regulation of advanced therapy medicinal products. Personalized medicine 19 (3) (2022)
Warit Ruanglertboon, Michael J Sorich, Ashley M Hopkins, Andrew Rowland
Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Warit Ruanglertboon, Michael J Sorich, Jessica M Logan, Andrew Rowland, Ashley M Hopkins
The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib. Journal of cancer research and clinical oncology 146 (10) (2020)
Warit Ruanglertboon, Michael J Sorich, Andrew Rowland, Ashley M Hopkins
Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients. International journal of clinical oncology 25 (9) (2020)

Warit Ruanglertboon.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Warit Ruanglertboon